FindTrial
Sign In

High resolution anoscopy

PROCEDURE6 trials

Sponsors

Kirby Institute, ANRS, Emerging Infectious Diseases, National Cancer Institute (NCI), Baylor College of Medicine, University of California, San Francisco

Conditions

AIDS-Related Anal CarcinomaAIDS-Related Cervical CarcinomaAnal AIN3Anal Basaloid CarcinomaAnal Canal Cloacogenic CarcinomaAnal HPV InfectionAnal HSILAnal High Grade Squamous Intraepithelial Lesion

Phase 1

The Effectiveness of High Resolution Microendoscopy for People Living With HIV
CompletedNCT04563754
Baylor College of MedicineAnal High Grade Squamous Intraepithelial Lesion
Start: 2019-07-30End: 2025-03-28Updated: 2025-04-23

Phase 3

Nivolumab After Combined Modality Therapy in Treating Patients With High Risk Stage II-IIIB Anal Cancer
Active, not recruitingNCT03233711
National Cancer Institute (NCI)Anal Basaloid Carcinoma, Anal Canal Cloacogenic Carcinoma, Anal Margin Squamous Cell Carcinoma +2
Start: 2018-07-05End: 2027-12-31Target: 344Updated: 2026-04-03

Unknown Phase

Study of the Prevention of Anal Cancer
CompletedNCT02007421
Kirby InstituteCancer, Human Papillomavirus
Start: 2010-09-10End: 2018-12-04Updated: 2019-12-02
Human Papillomavirus Infection and Related Anal Lesions in HIV-positive Men Who Have Sex With Men
CompletedNCT02287961
ANRS, Emerging Infectious DiseasesHiv Infection
Start: 2014-12-02End: 2022-06-30Updated: 2024-08-20
Screening Algorithms for Cervical and Anal High-Grade Squamous Intraepithelial Lesions in People With HIV in Mexico and Puerto Rico
Active, not recruitingNCT05074264
University of California, San FranciscoAIDS-Related Anal Carcinoma, AIDS-Related Cervical Carcinoma, High Grade Anal Intraepithelial Neoplasia +2
Start: 2021-11-30End: 2027-12-31Updated: 2025-11-07
Anal Cancer Prevention in High-Risk Categories of Men Who Have Sex With Men
Not yet recruitingNCT07123558
Bispebjerg HospitalAnal AIN3, Anal HPV Infection, Anal HSIL
Start: 2025-11-01End: 2027-10-31Target: 700Updated: 2025-08-14

Related Papers

Biomarkers of pembrolizumab efficacy in advanced anal squamous cell carcinoma: analysis of a phase II clinical trial and a cohort of long-term responders
Journal for ImmunoTherapy of Cancer2024-01-0110 citations
Effect of Human Papillomavirus Vaccine to Interrupt Recurrence of Vulvar and Anal Neoplasia (VIVA)
JAMA Network Open2019-04-1230 citations
Human Papillomavirus 16–Specific T-Cell Responses and Spontaneous Regression of Anal High-Grade Squamous Intraepithelial Lesions
The Journal of Infectious Diseases2014-08-1935 citations